ATE333272T1 - Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen - Google Patents

Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen

Info

Publication number: ATE333272T1
Authority: AT; Austria
Prior art keywords: naphthoquinone; hydroxy; foods; metabolism; bone diseases
Prior art date: 1999-10-19

Application number

AT00969840T

Other languages

English (en)

Inventor

Kazuo Nagai

Jetae Woo

Yoshiro Sato

Kouichiro Hashimoto

Naoki Taketomo

Nobuo Yoda

Hiroshi Tsuchida

Original Assignee

Meiji Dairies Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-19

Filing date

2000-10-18

Publication date

2006-08-15

2000-10-18 Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE333272T1 publication Critical patent/ATE333272T1/de

Links

235000013305 food Nutrition 0.000 title abstract 2
208000020084 Bone disease Diseases 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
238000011282 treatment Methods 0.000 title 1
KQPYUDDGWXQXHS-UHFFFAOYSA-N juglone Chemical compound O=C1C=CC(=O)C2=C1C=CC=C2O KQPYUDDGWXQXHS-UHFFFAOYSA-N 0.000 abstract 3
FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 abstract 2
GXDIXDKPIUJGOV-UHFFFAOYSA-N 3-amino-1,4-dioxonaphthalene-2-carboxylic acid Chemical compound C1=CC=C2C(=O)C(N)=C(C(O)=O)C(=O)C2=C1 GXDIXDKPIUJGOV-UHFFFAOYSA-N 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 2
229930192627 Naphthoquinone Natural products 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
CSFWPUWCSPOLJW-UHFFFAOYSA-N lawsone Chemical compound C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 abstract 2
SVPKNMBRVBMTLB-UHFFFAOYSA-N 2,3-dichloronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(Cl)=C(Cl)C(=O)C2=C1 SVPKNMBRVBMTLB-UHFFFAOYSA-N 0.000 abstract 1
208000029725 Metabolic bone disease Diseases 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
230000004097 bone metabolism Effects 0.000 abstract 1
230000037118 bone strength Effects 0.000 abstract 1
239000004310 lactic acid Substances 0.000 abstract 1
235000014655 lactic acid Nutrition 0.000 abstract 1
-1 naphthoquinone compound Chemical class 0.000 abstract 1
150000002791 naphthoquinones Chemical class 0.000 abstract 1
230000002642 osteogeneic effect Effects 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
235000019260 propionic acid Nutrition 0.000 abstract 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/61—Propionibacterium
- A23V2400/617—Freudenreichii

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00969840T 1999-10-19 2000-10-18 Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen ATE333272T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP29605399		1999-10-19
JP29605299		1999-10-19

Publications (1)

Publication Number	Publication Date
ATE333272T1 true ATE333272T1 (de)	2006-08-15

Family

ID=26560520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00969840T ATE333272T1 (de)	1999-10-19	2000-10-18	Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen

Country Status (11)

Country	Link
US (2)	US7709537B1 (de)
EP (1)	EP1230920B1 (de)
JP (1)	JP4750991B2 (de)
KR (2)	KR100898756B1 (de)
CN (1)	CN1187043C (de)
AT (1)	ATE333272T1 (de)
AU (1)	AU780598B2 (de)
CA (1)	CA2388243C (de)
DE (1)	DE60029469T2 (de)
TW (2)	TWI248359B (de)
WO (1)	WO2001028547A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60029469T2 (de) *	1999-10-19	2007-03-01	Meiji Dairies Corp.	Verwendung von nahrungsmitteln in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen
JP4653785B2 (ja) *	2001-08-10	2011-03-16	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
CN1312285C (zh)	2001-08-10	2007-04-25	明治乳业株式会社	制造1,4－二羟基－2萘甲酸的方法
JP2004315477A (ja) *	2003-04-18	2004-11-11	Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan	骨吸収抑制剤
AU2005232497B2 (en)	2004-04-13	2010-04-29	Meiji Dairies Corporation	Preventive and/or therapeutic agent for inflammatory bowel diseases
JP5114200B2 (ja)	2005-08-26	2013-01-09	株式会社明治	抗アレルギー剤
CA2675729C (en)	2007-01-17	2015-05-12	Meiji Dairies Corporation	Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
KR20170059011A (ko) *	2007-11-27	2017-05-29	가부시키가이샤 메이지	유산균의 생잔성 향상제 및 생잔성 향상 방법, 및 식품 조성물
CN102753678B (zh) *	2009-04-15	2016-10-26	杜邦营养生物科学有限公司	具有产生甲基萘醌的优异能力的菌株
GB2476644B (en)	2009-12-23	2012-11-14	Haomamedica Ltd	1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
KR101342791B1 (ko)	2012-08-16	2013-12-19	주식회사 제이케이뉴트라	1,4-디히드록시-2-나프토산 생산능을 가지는 락토바실러스 카제이 ｌｐ1 균주 및 이의 이용
KR102127108B1 (ko) *	2018-06-26	2020-06-26	고려대학교산학협력단	프로피오니바크테리움 후레우덴레이키, 이의 배양액 또는 이의 사균체를 유효성분으로 함유하는 골질환의 예방 또는 치료용 조성물
CN111650309A (zh) *	2020-07-16	2020-09-11	余文兵	一种含脂配方粉中维生素k1的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3011461C2 (de)	1980-03-25	1986-10-30	Dr. Madaus & Co, 5000 Köln	Verwendung von Propionibakterien
US5096718A (en) *	1982-09-17	1992-03-17	The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University	Preserving foods using metabolites of propionibacteria other than propionic acid
JPH07289273A (ja) *	1994-04-26	1995-11-07	Meiji Milk Prod Co Ltd	ナフトキノン誘導体
JP3315826B2 (ja)	1994-04-26	2002-08-19	明治乳業株式会社	ビフィズス菌増殖促進組成物
JPH08126473A (ja) *	1994-09-08	1996-05-21	Fuji Oil Co Ltd	油性組成物およびその製法並びにそれを用いた油性被覆菓子
JPH09194384A (ja) *	1996-01-19	1997-07-29	Snow Brand Milk Prod Co Ltd	ミネラル吸収促進剤
GB9613309D0 (en) *	1996-06-25	1996-08-28	Univ Sheffield	Quinone bacterial inhibitors
JP3505043B2 (ja)	1996-08-14	2004-03-08	株式会社ヤクルト本社	ビタミンｋ補給食品および骨粗鬆症予防・治療用食品
US5989612A (en) *	1996-10-11	1999-11-23	Rodia Inc.	Foods including antimycotic agent
JPH10158178A (ja)	1996-11-29	1998-06-16	Yakult Honsha Co Ltd	ミネラル吸収促進剤およびミネラル強化剤
JP3149403B2 (ja) *	1999-03-02	2001-03-26	明治乳業株式会社	ビフィズス菌によるオリゴ糖利用能改善剤
WO2000060950A1 (en)	1999-04-13	2000-10-19	Sigma-Tau Healthscience S.P.A.	Dietary supplement derived from fermented milks for the prevention of osteoporosis
GB9920578D0 (en) *	1999-08-31	1999-11-03	Nestle Sa	Composition for maintenance of bone or dental health or treatment of bone or dental disorders
DE60029469T2 (de) *	1999-10-19	2007-03-01	Meiji Dairies Corp.	Verwendung von nahrungsmitteln in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen

2000
- 2000-10-18 DE DE60029469T patent/DE60029469T2/de not_active Expired - Lifetime
- 2000-10-18 AU AU79473/00A patent/AU780598B2/en not_active Expired
- 2000-10-18 KR KR1020027004619A patent/KR100898756B1/ko not_active Expired - Lifetime
- 2000-10-18 EP EP00969840A patent/EP1230920B1/de not_active Expired - Lifetime
- 2000-10-18 JP JP2001531377A patent/JP4750991B2/ja not_active Expired - Fee Related
- 2000-10-18 CN CNB008145660A patent/CN1187043C/zh not_active Expired - Lifetime
- 2000-10-18 WO PCT/JP2000/007217 patent/WO2001028547A1/ja not_active Ceased
- 2000-10-18 KR KR1020067027347A patent/KR100866008B1/ko not_active Expired - Lifetime
- 2000-10-18 AT AT00969840T patent/ATE333272T1/de not_active IP Right Cessation
- 2000-10-18 CA CA2388243A patent/CA2388243C/en not_active Expired - Lifetime
- 2000-10-18 US US10/110,206 patent/US7709537B1/en not_active Expired - Lifetime
- 2000-10-19 TW TW089121955A patent/TWI248359B/zh not_active IP Right Cessation
- 2000-10-19 TW TW093127201A patent/TWI243673B/zh not_active IP Right Cessation
2005
- 2005-12-07 US US11/295,601 patent/US20060093651A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU7947300A (en)	2001-04-30
US7709537B1 (en)	2010-05-04
DE60029469T2 (de)	2007-03-01
EP1230920B1 (de)	2006-07-19
TW200509888A (en)	2005-03-16
EP1230920A1 (de)	2002-08-14
TWI248359B (en)	2006-02-01
CA2388243C (en)	2010-05-04
EP1230920A4 (de)	2004-09-29
US20060093651A1 (en)	2006-05-04
KR20020048959A (ko)	2002-06-24
CN1187043C (zh)	2005-02-02
AU780598B2 (en)	2005-04-07
WO2001028547A1 (en)	2001-04-26
DE60029469D1 (de)	2006-08-31
KR100866008B1 (ko)	2008-10-29
TWI243673B (en)	2005-11-21
CN1382043A (zh)	2002-11-27
KR100898756B1 (ko)	2009-05-25
JP4750991B2 (ja)	2011-08-17
KR20070011621A (ko)	2007-01-24
CA2388243A1 (en)	2001-04-26

Legal Events

Date	Code	Title	Description
2007-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE333272T1 (de)	2006-08-15	Verwendung von nahrungsmittel in der prophylaxe und behandlung von stoffwechselbedingten knochenerkrankungen
Mseddi et al.	2020	Thymus musilii Velen. as a promising source of potent bioactive compounds with its pharmacological properties: In vitro and in silico analysis
ES8603870A1 (es)	1986-01-01	Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ATE140687T1 (de)	1996-08-15	Bakterientötende zweiwertiges silber enthaltende zusammensetzungen
BR8900229A (pt)	1989-09-12	Uma composicao sinergistica biocida,uma composicao para higiene pessoal,uma composicao de produto para limpeza domestica e um processo para inibir o crescimento de microorganismos
EP1123655A4 (de)	2002-04-03	Bakterizide desinfizierende peressigsäure-zusammensetzung
UY26545A1 (es)	2001-07-31	" alimento para mascotas para tratar especies de helicobacter en mascotas."
BR0013958A (pt)	2002-05-14	Dieta de elevado teor de lipìdios
US5344850A (en)	1994-09-06	Topical composition for preventing or treating acne vulgaris
ES2057106T3 (es)	1994-10-16	Compuestos tensioactivos y un procedimiento para su preparacion.
SE0300002D0 (sv)	2003-01-03	New product
ES2059068T3 (es)	1994-11-01	Acilatos de acido lactico, sus sales, su procedimiento de preparacion y las composiciones que los contienen.
EP1027827A1 (de)	2000-08-16	Desinfektionsmittelzusammensetzung
DE69402004D1 (de)	1997-04-17	Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
ATE321553T1 (de)	2006-04-15	Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
ATE155343T1 (de)	1997-08-15	Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs
ATE164835T1 (de)	1998-04-15	Derivate von n-epsilon alkoxy- oder alkenoxy- carbonyl-lysin, ihre herstellung und verwendung in kosmetischen, pharmazeutischen, hygienischen und nahrhaften zusammensetzungen
DE60107505D1 (de)	2005-01-05	Wirksame Derivate der Valproinsäure zur Behandlung von neurologischen und psychotischen Störungen, und ein Verfahren zu ihrer Herstellung
DK0966455T3 (da)	2004-05-17	Oxirancarboxylsyrer til behandling af diabetes
WO2008069069A1 (ja)	2008-06-12	アミド化合物及びその塩、それを用いたバイオフィルム形成阻害剤及びバイオフィルム剥離剤
JP4607366B2 (ja)	2011-01-05	外用剤組成物
JP2010202562A (ja)	2010-09-16	フェノール系抗菌剤
IT1258788B (it)	1996-02-29	Derivati solforati di acidi biliari
ATE291353T1 (de)	2005-04-15	Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
GEP19970834B (en)	1997-02-10	2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone